Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Biotechnology Ltd.
Cambridge, England, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Cambridge Biotechnology Ltd. was a UK-based biotech company specializing in early-stage drug discovery, leveraging expertise from former Pfizer/Parke-Davis scientists. It developed proprietary platforms for identifying small molecule leads but did not advance any major programs into late-stage clinical development before being acquired by Biovitrum AB. The company was eventually divested and is no longer independently active.
- Therapeutic areas
- Neurology
- Modalities
- Small molecules
- Industry
- Biotech
Beyond the preview
Go deeper on Cambridge Biotechnology Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cambridge Biotechnology Ltd..